Related Experiment Video
Updated: Aug 6, 2026

Orthotopic Small Bowel Transplantation in Rats
Published on: November 6, 2012
Overweight and Obesity Based on Four Reference Systems in 18,382 Paediatric Patients with Type 1 Diabetes from
M Flechtner-Mors1, K O Schwab2, E E Fröhlich-Reiterer3
1Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, 89081 Ulm, Germany ; German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany.
Insights
Overweight and obesity prevalence in children with type 1 diabetes varies significantly based on the reference population used. This highlights the need for careful assessment to determine individual obesity-related risks.
Area of Science:
- Pediatrics
- Endocrinology
- Public Health
Background:
- Type 1 diabetes (T1D) management requires monitoring weight status.
- Prevalence of overweight and obesity in T1D pediatric populations can vary based on reference standards.
Purpose of the Study:
- To evaluate the prevalence of overweight and obesity in pediatric type 1 diabetes (T1D) subjects.
- To compare prevalence rates using four common reference populations: WHO, IOTF, AGA, and KiGGS.
Main Methods:
- Analysis of T1D patients aged 2-18 years from the German/Austrian DPV database (2000 and 2013).
- Prevalence of overweight (≥90th percentile) and obesity (≥97th percentile) determined using WHO, IOTF, AGA, and KiGGS reference populations.
- Time trend analysis conducted between 2000 and 2013.
Main Results:
- Overweight prevalence in 2000 ranged from 9.4% (KiGGS) to 22.3% (IOTF); in 2013, it ranged from 11.7% (KiGGS) to 24.8% (IOTF).
- Obesity prevalence in 2000 ranged from 1.8% (KiGGS) to 7.9% (WHO); in 2013, it ranged from 2.6% (KiGGS) to 9.6% (WHO).
- Overall prevalence of overweight and obesity increased from 2000 to 2006, with stabilization thereafter for girls and overweight in boys.
Conclusions:
- Significant differences in overweight and obesity prevalence were observed in pediatric T1D subjects depending on the reference population used.
- A more detailed individual assessment is necessary to accurately determine obesity-related risks in this population.
Aim:
To evaluate the prevalence of overweight and obesity in paediatric type 1 diabetes (T1D) subjects, based on four commonly used reference populations.
Methods:
Using WHO, IOTF, AGA (German pediatric obesity), and KiGGS (German Health Interview and Examination Survey for Children and Adolescents) reference populations, prevalence of overweight (≥90th percentile) and obesity (≥97th percentile) and time trend between 2000 (n = 9,461) and 2013 (n = 18,382) were determined in 2-18-year-old T1D patients documented in the German/Austrian DPV database.
Results:
In 2000, the overweight prevalence was the highest according to IOTF (22.3%), followed by WHO (20.8%), AGA (15.5%), and KiGGS (9.4%). The respective rates in 2013 were IOTF (24.8%), WHO (22.9%), AGA (18.2%), and KiGGS (11.7%). Obesity prevalence in 2000 was the highest according to WHO (7.9%), followed by AGA (4.5%), IOTF (3.1%), and KiGGS (1.8%). In 2013, the respective rates were WHO (9.6%), AGA (6.2%), IOTF (4.5%), and KiGGS (2.6%). Overall, the prevalence of overweight and obesity increased from 2000 to 2006 (p < 0.001) but showed stabilization thereafter in girls and overweight in boys.
Conclusion:
Overweight and obesity prevalence in T1D subjects differs significantly if it is assessed by four separate reference populations. More detailed assessment of each child is required to determine obesity-related risks.
Related Concept Videos
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Obesity
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

